Categories Earnings, Other Industries

Earnings Summary: Highlights of Warner Bros. Discovery’s (WBD) Q1 2024 report

Warner Bros. Discovery (NASDAQ: WBD), a leading media and entertainment company, reported financial results for the first quarter of 2024.

  • First-quarter total revenues decreased 7% year-over-year, both reported and ex-FX, to $9.96 billion
  • Studios revenues decreased 13% annually, ex-FX, to $2.82 billion; Networks revenues dropped 8% to $5.13 billion
  • Direct-to-Customer revenues increased modestly to $2.46 billion compared to the prior year quarter
  • Net loss available to Warner Bros. Discovery was $966 million in the March quarter, vs. a loss of $1.07 billion a year earlier
  • On a per-share basis, Q1 loss narrowed to $0.40 from $0.44 in the year-ago quarter
  • Adjusted EBITDA came in at $2.10 billion in the first quarter, compared to $2.61 billion a year earlier
  • Cash provided by operating activities was $585 million during the three months; free cash flow came in at $390 million

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top